News Image

Stay updated with the stocks that are on the move in today's pre-market session.

By Mill Chart

Last update: Apr 4, 2024

Before the US market kicks off on Thursday, let's examine the pre-market session and unveil the notable performers among the top gainers and losers.

Pre-market gainers

TickerChangeComment
RELI56.08%RELIANCE GLOBAL GROUP INC's (NASDAQ:RELI) shares surged 56.08% to reach $0.58 during the pre-market session on Thursday. In the last month the share price dropped with 26.83%.
HWH43.95%Exciting news for HWH INTERNATIONAL INC (NASDAQ:HWH) as their shares soared 43.95% to $2.26 during the pre-market session on Thursday. The stock is trading 57.0% higher than a month ago.
ZCMD37.66%Investors witnessed a remarkable surge in ZHONGCHAO INC-CLASS A (NASDAQ:ZCMD) during Thursday's pre-market session, with the stock price rising 37.66% to $2.12. Following yesterday's 22.22% increase, NASDAQ:ZCMD demonstrates further positive momentum in today's pre-market session with a 37.66% gain.
CXAIW36.68%KINS TECH GROUP CL A -CW25 (NASDAQ:CXAIW) experienced an impressive 36.68% increase in share price, reaching $0.41 during the pre-market session on Thursday. The stock is trading 149.0% higher than a month ago.
HUBC34.94%HUB CYBER SECURITY LTD (NASDAQ:HUBC) experienced an impressive 34.94% increase in share price, reaching $0.97 during the pre-market session on Thursday. A press release (HUB Cyber Security Acquires QPoint Technologies, Advancing its Plans for a Secured Data Fabric Ecosystem) was released earlier today.
SWVLW25.1%PIVOTAL HOLDINGS CORP -CW27's (NASDAQ:SWVLW) shares rose 25.1% to $0.03 during Thursday's pre-market session. This is a continuation of yesterday's gain of 36.57%.
GRRR22.95%GORILLA TECHNOLOGY GROUP INC's (NASDAQ:GRRR) stock price increased by 22.95% to $0.9. Earlier today the company had a press release: Gorilla Reports Record 2023 Financial Results.
MIMO16.99%AIRSPAN NETWORKS HOLDINGS IN's (NYSEARCA:MIMO) shares rose 16.99% to $0.13 during Thursday's pre-market session. In the last 3 months the stock gained 25.56%.
GORO15.57%Exciting news for GOLD RESOURCE CORP (NYSEARCA:GORO) as their shares soared 15.57% to $0.75 during the pre-market session on Thursday. After recording a 26.98% gain in the previous session, NYSEARCA:GORO maintains its positive trajectory in today's pre-market, with an additional 15.57% increase.
BROG15.34%BROOGE ENERGY LTD's (NASDAQ:BROG) shares surged 15.34% to reach $2.18 during the pre-market session on Thursday. Following a -12.9% loss in the previous session, NASDAQ:BROG displays significant price volatility in today's pre-market session. Yesterday the company had a press release: BROG FINAL DEADLINE: TOP RANKED ROSEN LAW FIRM Encourages Brooge Energy Limited Investors to Secure Counsel Before Important April 5 Deadline in Securities Class Action Filed by the Firm - BROG.

For the full premarket gainers list go to our premarket gainers page.

Pre-market losers

TickerChangeComment
VIEW-23.04%Investors observed a 23.04% decline in VIEW INC's (NASDAQ:VIEW) stock price, which now stands at $0.39 during Thursday's pre-market session. It looks like the bad days are not over yet: yesterday NASDAQ:VIEW also declined by -53.64% during the regular session. Two days ago the company had a press release: View, Inc. Reaches Agreement with Cantor Fitzgerald and RXR to Become a Private Company.
CASA-22.91%Investors observed a 22.91% decline in CASA SYSTEMS INC's (NASDAQ:CASA) stock price, which now stands at $0.04 during Thursday's pre-market session. The negative sentiment prevails for NASDAQ:CASA as it recorded a -78.64% decline during the regular session yesterday, followed by another decline of 22.91% in today's pre-market session. A press release (Casa Systems Initiates Court-Supervised Chapter 11 Sale Process for Businesses) was released yesterday.
FLGC-19.48%FLORA GROWTH CORP's (NASDAQ:FLGC) shares experienced a 19.48% decline, falling to $2.15 during Thursday's pre-market session. After yesterdays gain of 30.24%, it goes down with 19.48% in today's pre-market session.
TPET-12.15%TRIO PETROLEUM CORP's (NYSEARCA:TPET) shares fell 12.15% to $0.11. The struggles persist for NYSEARCA:TPET as it recorded a -12.46% decline during the regular session yesterday, indicating that the challenging days are not yet over.
TBIO-11.74%Thursday's pre-market session showed a 11.74% decrease in the stock price of TELESIS BIO INC (NASDAQ:TBIO), reaching $0.42. In the last 3 months the stock gained 32.13%.
ACHL-10.83%ACHILLES THERAPEUTICS PL-ADR's (NASDAQ:ACHL) stock price is declining with 10.83% to a price of $1.07. A press release (Achilles Therapeutics Reports Fourth Quarter and Year-End 2023 Financial Results and Recent Business Highlights) was released earlier today.
MRIN-10.71%MARIN SOFTWARE INC's (NASDAQ:MRIN) stock price decreased by 10.71% to $0.25. In the last 3 months the share price dropped with 26.32%.
QLI-9.95%Investors observed a 9.95% decline in QILIAN INTERNATIONAL HOLDING's (NASDAQ:QLI) stock price, which now stands at $0.63 during Thursday's pre-market session. Despite a promising gain of 20.6% yesterday, NASDAQ:QLI faces downward pressure with a 9.95% decline in today's pre-market session.
UAMY-9.6%The stock price of UNITED STATES ANTIMONY CORP (NYSEARCA:UAMY) is experiencing a decline of 9.6%, reaching $0.24 in today's pre-market session on Thursday. Despite a promising gain of 13.45% yesterday, NYSEARCA:UAMY faces downward pressure with a 9.6% decline in today's pre-market session.
NCNA-9.45%Despite yesterday's decline, NUCANA PLC-ADR (NASDAQ:NCNA) experienced a further 9.45% decrease in share price during Thursday's pre-market session, reaching $0.24. Yesterday's 14.14% gain in NASDAQ:NCNA gives way to a 9.45% decrease in today's pre-market session, showcasing market fluctuations.

Our premarket losers page will show you the full list.

Back

ACHILLES THERAPEUTICS PL-ADR

NASDAQ:ACHL (5/3/2024, 7:00:00 PM)

After market: 0.81 +0.01 (+0.78%)

0.8037

+0.02 (+3.04%)

ACHL News

News Imagea month ago - InvestorPlaceACHL Stock Earnings: Achilles Therapeutics Misses EPS for Q4 2023

ACHL stock results show that Achilles Therapeutics missed analyst estimates for earnings per share the fourth quarter of 2023.

News Imagea month ago - BusinessInsiderACHL Stock Earnings: Achilles Therapeutics Misses EPS for Q4 2023

InvestorPlace - Stock Market News, Stock Advice & Trading Tips Achilles Therapeutics (NASDAQ:ACHL) just reported results for the fourth quarte...

News Imagea month ago - InvestorPlaceToday’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Thursday

We're diving into the biggest pre-market stock movers that traders are going to want to keep an eye on for Thursday morning!

News Imagea month ago - Achilles Therapeutics PLCAchilles Therapeutics Reports Fourth Quarter and Year-End 2023 Financial Results and Recent Business Highlights
News Imagea month ago - Achilles Therapeutics PLCAchilles Therapeutics Reports Fourth Quarter and Year-End 2023 Financial Results and Recent Business Highlights

– Provided interim Phase I/IIa update on clonal neoantigen reactive T cells in advanced NSCLC and melanoma – – Improved VELOS™ manufacturing process...

News Imagea month ago - Achilles Therapeutics PLCAchilles Therapeutics Provides Interim Phase I/IIa Update on Clonal Neoantigen Reactive T Cells in Advanced NSCLC and Melanoma Including First Patients Dosed with Enhanced Host Conditioning
News Imagea month ago - Achilles Therapeutics PLCAchilles Therapeutics Provides Interim Phase I/IIa Update on Clonal Neoantigen Reactive T Cells in Advanced NSCLC and Melanoma Including First Patients Dosed with Enhanced Host Conditioning

– Improved VELOS™ manufacturing process delivering higher cNeT doses – – Protocols updated to evaluate the benefit of enhanced host conditioning, with...

News Image3 months ago - Achilles Therapeutics PLCAchilles Therapeutics to Present at the 10th Annual Immuno-Oncology 360 Conference
News Image3 months ago - Achilles Therapeutics PLCAchilles Therapeutics to Present at the 10th Annual Immuno-Oncology 360 Conference

LONDON, Feb. 05, 2024 (GLOBE NEWSWIRE) -- Achilles Therapeutics plc (NASDAQ: ACHL), a clinical-stage biopharmaceutical company developing AI-powered...

News Image5 months ago - Achilles Therapeutics PLCAchilles Therapeutics Announces Publication of Nature Cancer ‘Comment’ on Strategy for Improved Neoantigen Immunogenicity Prediction

Newly developed computational tools and large datasets with low bias will lead to robust neoantigen prediction and improved personalized cancer therapies

News Image5 months ago - Achilles Therapeutics PLCAchilles Therapeutics Announces Publication of Nature Cancer ‘Comment’ on Strategy for Improved Neoantigen Immunogenicity Prediction

Newly developed computational tools and large datasets with low bias will lead to robust neoantigen prediction and improved personalized cancer therapies...

News Image6 months ago - Achilles Therapeutics PLCAchilles Therapeutics Reports Third Quarter 2023 Financial Results and Recent Highlights
ACHL Links
Follow us for more